The molecular programme of tumour reversion: the steps beyond malignant transformation

How cells become malignant has preoccupied scientists for over a century. However, the converse question is also valid: are tumour cells capable of reverting from their malignant state? Askanazy's studies in 1907 indicated that teratoma cells could differentiate into normal somatic tissues and current evidence indicates that some tumour cells have acquired the molecular circuitry that results in the negation of chromosomal instability, translocations, oncogene activation and loss of tumour suppressor genes. Studying these extremely rare events of tumour reversion and deciphering these pathways, which involve SIAH1, presenilin 1, TSAP6 and translationally controlled tumour protein (TCTP), could lead to new avenues in cancer treatment.

[1]  L. Sachs,et al.  Reversion of Properties in Cells transformed by Polyoma Virus , 1968, Nature.

[2]  A. Gartel,et al.  Activation and repression of p21WAF1/CIP1 transcription by RB binding proteins , 1998, Oncogene.

[3]  A. Blomberg,et al.  Two‐dimensional electrophoretic separation of yeast proteins using a non‐linear wide range (pH 3–10) immobilized pH gradient in the first dimension; reproducibility and evidence for isoelectric focusing of alkaline (pI >7) proteins , 1997, Yeast.

[4]  E. Lees,et al.  Role for BRG1 in Cell Cycle Control and Tumor Suppression , 2004, Molecular and Cellular Biology.

[5]  U. Lendahl,et al.  Hypoxia requires notch signaling to maintain the undifferentiated cell state. , 2005, Developmental cell.

[6]  E. Vermaas,et al.  In vitro cloning of complex mixtures of DNA on microbeads: physical separation of differentially expressed cDNAs. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[7]  R. Bassin,et al.  Reversion of Murine Sarcoma Virus Transformed Mouse Cells: Variants without a Rescuable Sarcoma Virus , 1972, Science.

[8]  D. Bowtell,et al.  Siah2 Regulates Stability of Prolyl-Hydroxylases, Controls HIF1α Abundance, and Modulates Physiological Responses to Hypoxia , 2004, Cell.

[9]  A. Israël,et al.  Siah-1 binds and regulates the function of Numb , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Rithy K. Roth,et al.  Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays , 2000, Nature Biotechnology.

[11]  T. Hofmann,et al.  Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR , 2008, Nature Cell Biology.

[12]  H. Kitayama,et al.  Detection of genes with a potential for suppressing the transformed phenotype associated with activated ras genes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[13]  T. Rafnar,et al.  Molecular identification of an IgE-dependent histamine-releasing factor. , 1995, Science.

[14]  D. Pollen,et al.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease , 1995, Nature.

[15]  S. Prieur,et al.  Biological models and genes of tumor reversion: Cellular reprogramming through tpt1/TCTP and SIAH-1 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Xiaofeng Yang,et al.  An N-terminal region of translationally controlled tumor protein is required for its antiapoptotic activity , 2005, Oncogene.

[17]  Pier Paolo Di Fiore,et al.  NUMB controls p53 tumour suppressor activity , 2008, Nature.

[18]  Y. Jan,et al.  The Drosophila Numb protein inhibits signaling of the Notch receptor during cell-cell interaction in sensory organ lineage. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Lotem,et al.  Epigenetics wins over genetics: induction of differentiation in tumor cells. , 2002, Seminars in cancer biology.

[20]  Translational regulation of the mammalian growth-related protein P23: involvement of eIF-4E. , 1994, Cellular & molecular biology research.

[21]  C. Ross,et al.  Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Dausset,et al.  The p53-inducible TSAP6 gene product regulates apoptosis and the cell cycle and interacts with Nix and the Myt1 kinase , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Antonio Iavarone,et al.  Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F , 1998, Oncogene.

[24]  C. P. Oliver,et al.  A REVERSION TO WILD-TYPE ASSOCIATED WITH CROSSING-OVER IN DROSOPHILA MELANOGASTER. , 1940, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Laurence Zitvogel,et al.  Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell derived exosomes , 1998, Nature Medicine.

[26]  Pierce Gb.  The cancer cell and its control by the embryo. Rous-Whipple Award lecture. , 1983 .

[27]  Christine Chomienne,et al.  The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locus , 1990, Nature.

[28]  T. Efferth,et al.  Detection of apoptosis in KG-1a leukemic cells treated with investigational drugs. , 1996, Arzneimittel-Forschung.

[29]  Vikram Devgan,et al.  p21WAF1/Cip1 is a negative transcriptional regulator of Wnt4 expression downstream of Notch1 activation. , 2005, Genes & development.

[30]  S. Artavanis-Tsakonas,et al.  Notch Signaling : Cell Fate Control and Signal Integration in Development , 1999 .

[31]  G. Fiucci,et al.  Genomic organization and expression of mouse Tpt1 gene. , 2003, Genomics.

[32]  Michael S. Wolfe,et al.  Presenilin: Running with Scissors in the Membrane , 2007, Cell.

[33]  K. Kratochwil,et al.  Induction and differentiation of an epithelial tumour in the newt (Triturus cristatus). , 1962, Journal of embryology and experimental morphology.

[34]  K. Illmensee,et al.  Normal genetically mosaic mice produced from malignant teratocarcinoma cells. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[35]  M. Mattson,et al.  Calbindin D28k blocks the proapoptotic actions of mutant presenilin 1: reduced oxidative stress and preserved mitochondrial function. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M. Mirande,et al.  Translationally controlled tumor protein acts as a guanine nucleotide dissociation inhibitor on the translation elongation factor eEF1A , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[37]  A. C. Braun,et al.  Recovery of tumor cells from effects of the tumor-inducing principle in crown gall. , 1951, Science.

[38]  David D L Bowtell,et al.  A binding motif for Siah ubiquitin ligase , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[39]  H. J. Woerdenbag,et al.  Stereochemistry-dependent cytotoxicity of some artemisinin derivatives. , 1997, Journal of natural products.

[40]  Y. Jan,et al.  Asymmetric distribution of numb protein during division of the sensory organ precursor cell confers distinct fates to daughter cells , 1994, Cell.

[41]  Laurence Zitvogel,et al.  Exosomes: composition, biogenesis and function , 2002, Nature Reviews Immunology.

[42]  G. Rubin,et al.  seven in absentia, a gene required for specification of R7 cell fate in the Drosophila eye , 1990, Cell.

[43]  P. Pelicci,et al.  Numb Is an Endocytic Protein , 2000, The Journal of cell biology.

[44]  J. Rommelaere,et al.  Minute virus of mice inhibits cell transformation by simian virus 40 , 1982, Nature.

[45]  R. Brinster.  THE EFFECT OF CELLS TRANSFERRED INTO THE MOUSE BLASTOCYST ON SUBSEQUENT DEVELOPMENT , 1974, The Journal of experimental medicine.

[46]  W. Park,et al.  Inactivating mutations of the Siah-1 gene in gastric cancer , 2004, Oncogene.

[47]  D. Israeli,et al.  A novel p53‐inducible gene, PAG608, encodes a nuclear zinc finger protein whose overexpression promotes apoptosis , 1997, The EMBO journal.

[48]  G. B. Pierce.  The cancer cell and its control by the embryo. Rous-Whipple Award lecture. , 1983, The American journal of pathology.

[49]  M. Oren,et al.  Siah-1b is a direct transcriptional target of p53: identification of the functional p53 responsive element in the siah-1b promoter. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[50]  J. Dame,et al.  The Plasmodium falciparum Translationally Controlled Tumor Protein Homolog and Its Reaction with the Antimalarial Drug Artemisinin* , 1998, The Journal of Biological Chemistry.

[51]  Hyung-Sik Kang,et al.  Molecular Identification of IgE-Dependent Histamine-Releasing Factor as a B Cell Growth Factor1 , 2001, The Journal of Immunology.

[52]  Rudolf Jaenisch,et al.  Ectopic Expression of Oct-4 Blocks Progenitor-Cell Differentiation and Causes Dysplasia in Epithelial Tissues , 2005, Cell.

[53]  Y. Bergman,et al.  Oct-3/4 is a dose-dependent oncogenic fate determinant. , 2003, Cancer cell.

[54]  M. Mattson,et al.  Wild-type and mutated presenilins 2 trigger p53-dependent apoptosis and down-regulate presenilin 1 expression in HEK293 human cells and in murine neurons , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[55]  Y. Jan,et al.  Control of Daughter Cell Fates during Asymmetric Division: Interaction of Numb and Notch , 1996, Neuron.

[56]  L. L. Reed,et al.  Gamma secretase inhibitor blocks Notch activation and induces apoptosis in Kaposi's sarcoma tumor cells , 2005, Oncogene.

[57]  H. Dombret,et al.  Treatment of first relapse in acute promyelocytic leukaemia with all-trans retinoic acid , 1990, The Lancet.

[58]  B. Goud,et al.  TSAP6 Facilitates the Secretion of Translationally Controlled Tumor Protein/Histamine-releasing Factor via a Nonclassical Pathway* , 2004, Journal of Biological Chemistry.

[59]  K. Raj,et al.  The role of Notch in tumorigenesis: oncogene or tumour suppressor? , 2003, Nature Reviews Cancer.

[60]  G. B. Pierce,et al.  MULTIPOTENTIALITY OF SINGLE EMBRYONAL CARCINOMA CELLS. , 1964, Cancer research.

[61]  Pei-jun Zhang,et al.  The expression of AmphiTCTP, a TCTP orthologous gene in amphioxus related to the development of notochord and somites. , 2007, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

[62]  J. Sklar,et al.  TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms , 1991, Cell.

[63]  D. Israeli,et al.  Isolation of 10 differentially expressed cDNAs in p53-induced apoptosis: activation of the vertebrate homologue of the drosophila seven in absentia gene. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[64]  J. Marine,et al.  TCTP protects from apoptotic cell death by antagonizing bax function , 2008, Cell Death and Differentiation.

[65]  K. Kinzler,et al.  Cancer genes and the pathways they control , 2004, Nature Medicine.

[66]  A. C. Braun,et al.  A DEMONSTRATION OF THE RECOVERY OF THE CROWN-GALL TUMOR CELL WITH THE USE OF COMPLEX TUMORS OF SINGLE-CELL ORIGIN. , 1959, Proceedings of the National Academy of Sciences of the United States of America.

[67]  G Cesareni,et al.  Binding specificity and in vivo targets of the EH domain, a novel protein-protein interaction module. , 1997, Genes & development.

[68]  F. Alt,et al.  Activating Notch1 mutations in mouse models of T-ALL. , 2005, Blood.

[69]  T. P. Neufeld,et al.  PHYL Acts to Down-Regulate TTK88, a Transcriptional Repressor of Neuronal Cell Fates, by a SINA-Dependent Mechanism , 1997, Cell.

[70]  L. Chin,et al.  Nuclear cloning of embryonal carcinoma cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[71]  S. Elledge,et al.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.

[72]  N. Hattori,et al.  Siah-1 Facilitates Ubiquitination and Degradation of Synphilin-1* , 2003, Journal of Biological Chemistry.

[73]  N. Hay,et al.  Mutant Presenilin-1 Induces Apoptosis and Downregulates Akt/PKB , 1999, The Journal of Neuroscience.

[74]  P. Gönczy.  Mechanisms of asymmetric cell division: flies and worms pave the way , 2008, Nature Reviews Molecular Cell Biology.

[75]  G. B. Pierce,et al.  Testicular teratomas. I. Demonstration of teratogenesis by metamorphosis of multipotential Cells , 1959, Cancer.

[76]  J. Labbé,et al.  Chfr interacts and colocalizes with TCTP to the mitotic spindle , 2008, Oncogene.

[77]  Zhen-yi Wang,et al.  Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. , 1988, Haematology and blood transfusion.

[78]  S. Krauss,et al.  Continuing role for mouse Numb and Numbl in maintaining progenitor cells during cortical neurogenesis , 2004, Nature Neuroscience.

[79]  Y. Jan,et al.  numb, a gene required in determination of cell fate during sensory organ formation in Drosophila embryos , 1989, Cell.

[80]  K. Kinzler,et al.  p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. , 1995, Genes & development.

[81]  J. Rommens,et al.  Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene , 1995, Nature.

[82]  C. Larabell,et al.  Reversion of the Malignant Phenotype of Human Breast Cells in Three-Dimensional Culture and In Vivo by Integrin Blocking Antibodies , 1997, The Journal of cell biology.

[83]  J. J. Sharp,et al.  Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells , 2005, Nature Genetics.

[84]  A. Iavarone,et al.  Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression , 1997, Oncogene.

[85]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[86]  L. Hennighausen,et al.  Time-Sensitive Reversal of Hyperplasia in Transgenic Mice Expressing SV40 T Antigen , 1996, Science.

[87]  J C Reed,et al.  Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. , 2001, Molecular cell.

[88]  Hans Clevers,et al.  Destabilization of β-catenin by mutations in presenilin-1 potentiates neuronal apoptosis , 1998, Nature.

[89]  A. Kimchi,et al.  Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6 , 1991, Nature.

[90]  Y. Li,et al.  Photoreceptor Cell Differentiation Requires Regulated Proteolysis of the Transcriptional Repressor Tramtrack , 1997, Cell.

[91]  G. Brawerman,et al.  Messenger RNA species partially in a repressed state in mouse sarcoma ascites cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[92]  N. Cairns,et al.  Decreased brain histamine-releasing factor protein in patients with Down syndrome and Alzheimer's disease , 2001, Neuroscience Letters.

[93]  L. Vassilev,et al.  In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2 , 2004, Science.

[94]  S. Friedman,et al.  KLF6, a Candidate Tumor Suppressor Gene Mutated in Prostate Cancer , 2001, Science.

[95]  Mina J Bissell,et al.  Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment? , 2005, Cancer cell.

[96]  Mingyao Liu,et al.  Drosophila TCTP is essential for growth and proliferation through regulation of dRheb GTPase , 2007, Nature.

[97]  H. Green,et al.  Growth control in cultured cells: selection of sublines with increased sensitivity to contact inhibition and decreased tumor-producing ability. , 1968, Proceedings of the National Academy of Sciences of the United States of America.

[98]  F. Sigaux,et al.  A model for tumor suppression using H-1 parvovirus. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[99]  D. Givol,et al.  Induction of WAF1/CIP1 by a p53-independent pathway. , 1994, Cancer research.

[100]  M. Wolfe.  The γ-Secretase Complex: Membrane-Embedded Proteolytic Ensemble , 2006 .

[101]  D. Israeli,et al.  Inhibition of presenilin 1 expression is promoted by p53 and p21WAF-1 and results in apoptosis and tumor suppression , 1998, Nature Medicine.

[102]  D. Moras,et al.  Translationally controlled tumor protein is a target of tumor reversion. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[103]  M. R. Pritchard,et al.  Microarray analysis of perichondral and reserve growth plate zones identifies differential gene expressions and signal pathways. , 2008, Bone.

[104]  A. C. Braun.  The reversal of tumor growth. , 1965, Scientific American.

[105]  J. Bos.  Linking Rap to cell adhesion. , 2005, Current opinion in cell biology.

[106]  H. Kitayama,et al.  A ras-related gene with transformation suppressor activity , 1989, Cell.

[107]  J. Kubiak,et al.  Temporal regulation of embryonic M-phases. , 2008, Folia histochemica et cytobiologica.

[108]  H. Varmus,et al.  Factors affecting phenotypic reversion of rat cells transformed by avian sarcoma virus. , 1980, Cold Spring Harbor symposia on quantitative biology.

[109]  A. C. Williams,et al.  Interaction between β-catenin and HIF-1 promotes cellular adaptation to hypoxia , 2007, Nature Cell Biology.

[110]  A. Pardee,et al.  Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. , 1992, Science.

[111]  H. Toolan,et al.  Lack of Oncogenic Effect of the H-Viruses for Hamsters , 1967, Nature.

[112]  W. Nickel.  The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes. , 2003, European journal of biochemistry.

[113]  Iva Greenwald,et al.  Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene , 1995, Nature.

[114]  V. Lallemand-Breitenbach,et al.  How acute promyelocytic leukaemia revived arsenic , 2002, Nature Reviews Cancer.

[115]  J. Tsien,et al.  Forebrain degeneration and ventricle enlargement caused by double knockout of Alzheimer's presenilin-1 and presenilin-2. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[116]  L. Sachs.  Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukaemia , 1978, Nature.

[117]  L. Baki,et al.  Wild-Type But Not FAD Mutant Presenilin-1 Prevents Neuronal Degeneration by Promoting Phosphatidylinositol 3-Kinase Neuroprotective Signaling , 2008, The Journal of Neuroscience.

[118]  Raymond L. White,et al.  Siah-1 mediates a novel beta-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein. , 2001, Molecular cell.

[119]  A. van Belkum,et al.  Translationally Controlled Tumor Protein from Madurella mycetomatis, a Marker for Tumorous Mycetoma Progression , 2006, The Journal of Immunology.

[120]  D. Israeli,et al.  Behavioral alterations associated with apoptosis and down-regulation of presenilin 1 in the brains of p53-deficient mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[121]  Freddy Radtke,et al.  Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation , 2001, The EMBO journal.

[122]  K. Fujise,et al.  Characterization of Fortilin, a Novel Antiapoptotic Protein* , 2001, The Journal of Biological Chemistry.

[123]  Y. Gachet,et al.  The growth-related, translationally controlled protein P23 has properties of a tubulin binding protein and associates transiently with microtubules during the cell cycle. , 1999, Journal of cell science.

[124]  J. Marine,et al.  Exosome secretion, including the DNA damage-induced p53-dependent secretory pathway, is severely compromised in TSAP6/Steap3-null mice , 2008, Cell Death and Differentiation.

[125]  M. Noda.  Mechanisms of reversion , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[126]  M. Hendrix,et al.  p53-independent NOXA induction overcomes apoptotic resistance of malignant melanomas. , 2004, Molecular cancer therapeutics.

[127]  D. Le Paslier,et al.  Activation of the human homologue of the Drosophila sina gene in apoptosis and tumor suppression. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[128]  H. Yang-Yen,et al.  Stabilization and Enhancement of the Antiapoptotic Activity of Mcl-1 by TCTP , 2005, Molecular and Cellular Biology.

[129]  G. Hannon,et al.  Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD , 1995, Science.

[130]  Hans Clevers,et al.  Notch/γ-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells , 2005, Nature.

[131]  I. Macpherson.  Reversion in Hamster Cells Transformed by Rous Sarcoma Virus , 1965, Science.

[132]  Rudolf Jaenisch,et al.  Reprogramming of a melanoma genome by nuclear transplantation. , 2004, Genes & development.

[133]  H. Yang-Yen,et al.  A knockout mouse approach reveals that TCTP functions as an essential factor for cell proliferation and survival in a tissue- or cell type-specific manner. , 2007, Molecular biology of the cell.

[134]  C. McGlade,et al.  Mammalian Numb Proteins Promote Notch1 Receptor Ubiquitination and Degradation of the Notch1 Intracellular Domain* , 2003, Journal of Biological Chemistry.

[135]  F. Schweisguth,et al.  Regulation of Notch Signaling Activity , 2004, Current Biology.

[136]  J. Gurdon,et al.  Tpt1 Activates Transcription of oct4 and nanog in Transplanted Somatic Nuclei , 2007, Current Biology.

[137]  L. Piouffre,et al.  p21WAF-1 reorganizes the nucleus in tumor suppression. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[138]  D. Israeli,et al.  SIAH-1 promotes apoptosis and tumor suppression through a network involving the regulation of protein folding, unfolding, and trafficking: identification of common effectors with p53 and p21(Waf1). , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[139]  M. Vidal,et al.  Mammalian homologs of seven in absentia regulate DCC via the ubiquitin-proteasome pathway. , 1997, Genes & development.

[140]  E. Besa.  Acute promyelocytic leukemia. , 1991, Blood.

[141]  A. Booth,et al.  The Trojan exosome hypothesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[142]  D. Tenen,et al.  Reversibility of acute B-cell leukaemia induced by BCR–ABL1 , 2000, Nature Genetics.

[143]  C. Melief,et al.  B lymphocytes secrete antigen-presenting vesicles , 1996, The Journal of experimental medicine.

[144]  M. Gonzalez-Gaitan,et al.  The endocytic protein alpha-Adaptin is required for numb-mediated asymmetric cell division in Drosophila. , 2002, Developmental cell.

[145]  R. Weinberg,et al.  The Biology of Cancer , 2006 .

[146]  G. Thomas,et al.  Transcriptional and translational control of cytoplasmic proteins after serum stimulation of quiescent Swiss 3T3 cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[147]  Mary J. C. Hendrix,et al.  Reprogramming metastatic tumour cells with embryonic microenvironments , 2007, Nature Reviews Cancer.

[148]  A. Levine,et al.  The regulation of exosome secretion: a novel function of the p53 protein. , 2006, Cancer research.

[149]  L. Khachigian,et al.  Ets-1 Protects Vascular Smooth Muscle Cells from Undergoing Apoptosis by Activating p21WAF1/Cip1 , 2003, Journal of Biological Chemistry.

[150]  S. Artavanis-Tsakonas,et al.  Neoplastic transformation by truncated alleles of human NOTCH1/TAN1 and NOTCH2 , 1997, Molecular and cellular biology.

[151]  S. Elledge,et al.  p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells , 1995, Science.

[152]  H. Shimada,et al.  Bovine oocytes with the potential to reprogram somatic cell nuclei have a unique 23-kDa protein, phosphorylated transcriptionally controlled tumor protein (TCTP). , 2007, Cloning and stem cells.